Back
NeuroBo Pharmaceuticals Vs. Mirum Pharmaceuticals Industry Stock Comparison
Sell
20
NRBO
NeuroBo Pharmaceuticals
Last Price:
2.41
Seasonality Move:
-8.74%
Buy
87
MIRM
Mirum Pharmaceuticals
Last Price:
46.18
Seasonality Move:
40.11%
Sell
20
NeuroBo Pharmaceuticals (NRBO)
is a Sell
Is NeuroBo Pharmaceuticals a Buy, Sell or Hold?
- The current NeuroBo Pharmaceuticals [NRBO] share price is $2.39. The Score for NRBO is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
- NRBO is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
87
Mirum Pharmaceuticals (MIRM)
is a Buy
Is Mirum Pharmaceuticals a Buy, Sell or Hold?
- The current Mirum Pharmaceuticals [MIRM] share price is $46.26. The Score for MIRM is 87, which is 74% above its historic median score of 50, and infers lower risk than normal.
- MIRM is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
NRBO Stock Price Chart
What is NeuroBo Pharmaceuticals's stock price today?
-
The NeuroBo Pharmaceuticals share price today is $2.39
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NRBO is experiencing selling pressure, which indicates risk of future bearish movement.
MIRM Stock Price Chart
What is Mirum Pharmaceuticals's stock price today?
-
The Mirum Pharmaceuticals share price today is $46.26
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MIRM is experiencing slight selling pressure.
NRBO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.11 | Sell |
| Relative Strength Index (14 RSI): | 36.5 | Sell |
| Chaikin Money Flow: | -55184 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.52 - 2.86) | Sell |
| Bollinger Bands (100): | (2.82 - 4.26) | Sell |
MIRM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.11 | Buy |
| Relative Strength Index (14 RSI): | 76.85 | Buy |
| Chaikin Money Flow: | -49228 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (38.59 - 42.13) | Buy |
| Bollinger Bands (100): | (37.24 - 42.18) | Buy |
NRBO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.62 | Sell |
| 20-day SMA: | 2.71 | Sell |
| 50-day SMA: | 2.97 | Sell |
| 200-day SMA: | 3.92 | Sell |
| 8-day EMA: | 2.59 | Sell |
| 20-day EMA: | 2.68 | Sell |
| 50-day EMA: | 2.95 | Sell |
| 200-day EMA: | 4.84 | Sell |
MIRM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 42.37 | Buy |
| 20-day SMA: | 40.56 | Buy |
| 50-day SMA: | 40.1 | Buy |
| 200-day SMA: | 33.1 | Buy |
| 8-day EMA: | 42.8 | Buy |
| 20-day EMA: | 41.27 | Buy |
| 50-day EMA: | 40.23 | Buy |
| 200-day EMA: | 35.19 | Buy |
NeuroBo Pharmaceuticals Earnings Growth & NRBO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Mirum Pharmaceuticals Earnings Growth & MIRM Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.87 per share, and an increase next year of $0.59 per share.
NeuroBo Pharmaceuticals Technical Analysis
| Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Mirum Pharmaceuticals Technical Analysis
| Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||